Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB vs CEMIPLIMAB-RWLC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEMIPLIMAB vs CEMIPLIMAB-RWLC: Safety Overview

Metric CEMIPLIMAB CEMIPLIMAB-RWLC
Total FAERS Reports 1,020 1,554
Deaths Reported 175 323
Death Rate 17.2% 20.8%
Hospitalizations 651 441
Average Patient Age 68.9 yrs 70.2 yrs
% Female Patients 36.6% 40.6%
Manufacturer Regeneron Pharmaceuticals, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status N/A Prescription